Exodus Point Capital Management, LP Longboard Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 41,169 shares of LBPH stock, worth $1.44 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
41,169Holding current value
$1.44 Million% of portfolio
0.01%Shares
5 transactions
Others Institutions Holding LBPH
# of Institutions
106Shares Held
30MCall Options Held
16.3KPut Options Held
56.5K-
Cormorant Asset Management, LP Boston, MA3.35MShares$117 Million4.17% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.94MShares$103 Million0.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.22MShares$77.3 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.14MShares$74.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.87MShares$65.1 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $474M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...